Recently, IL-6 stimulation augmented mTOR activation in idiopathic multicentric Castleman disease (iMCD) patients was reported, furthermore, the degree of mTOR activation in iMCD was comparable to ALPS. The gene discussed is MTOR; the disease is autoimmune lymphoproliferative syndrome.